[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

$6163b

Market volatility continues to dominate discussions as $6163b faces downward price pressure. Community members are actively engaging, seeking clarity amidst regulatory uncertainties.

About $6163b

$6163b is a digital asset focused on decentralized finance and blockchain technology.

Insights #

$6163b mentions hit X which is XXX% higher than it's daily average.
$6163b engagements hit 26K which is 1342% higher than it's daily average.
$6163b creators hit X which is XXX% higher than it's daily average.
$6163b Creators hit a 52-Week high of X for the day
$6163b Creators hit an all time of X for the day
$6163b Engagements hit a 52-Week high of XXXXXX for the day
$6163b Engagements hit an all time of XXXXXX for the day
$6163b Mentions hit a 52-Week high of X for the day
$6163b Mentions hit an all time of X for the day

Engagements: XXXXXX #

Engagements Line Chart
Engagements 24-Hour Time-Series Raw Data
Current Value: XXXXXX
Daily Average: XXXXX
6 Months: XXXXXX +7,238%
1 Year: XXXXXX +13,071%
1-Year High: XXXXXX on 2025-10-31
1-Year Low: X on 2025-06-21

Social Network	X
Engagements	XXXXXX

Mentions: X #

Mentions Line Chart
Mentions 24-Hour Time-Series Raw Data
Current Value: X
Daily Average: X
6 Months: X -XX%
1 Year: XX +1,200%
1-Year High: X on 2025-10-31
1-Year Low: X on 2024-12-04

Social Network	X
Mentions	XX

Creators: X #

Creators Line Chart
Creators 24-Hour Time-Series Raw Data
X unique social accounts have posts mentioning $6163b in the last XX hours which is up XX% from X in the previous XX hours Daily Average: X
6 Months: X +13%
1 Year: XX +1,500%
1-Year High: X on 2025-10-31
1-Year Low: X on 2024-12-04

Top assets mentioned In the posts about $6163b in the last XX hours

Eli Lilly and Company (LLY) Eli Lilly and Company (LLY) Novo-Nordisk (NVO)

Top topics mentioned In the posts about $6163b in the last XX hours

stocks healthcare, eli lilly, $lly, $1607b, $635b, $1760b, $630b, $176b, $652b, $nvo, $63b, $60b, $62b, investment, money, should be, instead of, $630635b, battle of, rahul

Top Social Posts #

Top posts by engagements in the last XX hours

Showing only X posts for non-authenticated requests. Use your API key in requests for full results.

"🔥 $LLY vs $NVO The Battle of the Obesity Kings $NVO is busy spending on acquisitions while $LLY just dropped another monster quarter 💪 Eli Lilly Q3: 💰 Revenue: $17.6B (vs $16.07B est) +54% YoY 📈 EPS (Non-GAAP): $XXXX (vs $XXXX est) 🧾 Gross Margin: XXXX% 🚀 FY25 Guidance Raised: Revenue: $63.063.5B (vs $61.63B est) EPS: $23.00$23.70 (vs $XXXXX est) CEO David Ricks: Lilly delivered another strong quarter driven by demand for our incretin portfolio. Were expanding globally scaling capacity and building the future of metabolic health. $LLY is executing flawlessly scaling innovating and"
X Link @rahuls61193 2025-10-30T17:57Z XXX followers, XX engagements

"$LLY Eli Lilly Q325 Earnings Highlights 🔹 Revenue: $17.60B (Est. $16.07B) 🟢; UP +54% YoY 🔹 EPS (Non-GAAP): $XXXX (Est. $5.89) 🟢 🔹 Gross Margin: XXXX% FY25 Guidance 🔹 Revenue: $63.0B$63.5B (Est. $61.63B) 🟢 🔹 EPS (Non-GAAP): $23.00$23.70 (Est. $22.50) 🟢 🔹 Adj. Gross Margin: XX% 🔹 Performance Margin: 45%46% (Non-GAAP) Segment 🔹 Mounjaro: $6.52B; UP +109% YoY 🔹 Zepbound: $3.59B; UP +185% YoY 🔹 Verzenio: $1.47B; UP +7% YoY Other Metrics 🔹 U.S. Revenue: $11.30B; UP +45% YoY 🔹 OUS Revenue: $6.30B; UP +74% YoY CEO Commentary 🔸 Lilly delivered another strong quarter with XX% revenue"
X Link @dominic_pirrone 2025-10-30T14:34Z 5482 followers, XXX engagements

"$LLY Eli Lilly reports Q3 EPS $XXXX consensus $XXXX -- Q3 revenue $17.6B consensus $16.07B. -- Raises FY25 EPS view to $23.00-$23.70 from $21.75-$23.00 consensus $XXXXX. -- Raises FY25 revenue view to $63B-$63.5B from $60B-$62B consensus $61.63B"
X Link @CorleoneDon77 2025-10-30T11:17Z 6449 followers, XXX engagements

"$NVO busy spending money on acquisitions. Value = unclear. Meanwhile $LLY with another great quarter. Maybe I should be investing in $LLY instead of $NVO Eli Lilly's Q3 numbers: - Revenue: $17.60B (Est. $16.07B) 🟢+54% YoY - EPS (Non-GAAP): $XXXX (Est. $5.89) 🟢 - Gross Margin: 82.9%🟢 FY25 Guidance raised -- - Revenue: $63.0B$63.5B (Est. $61.63B) 🟢 - EPS (Non-GAAP): $23.00$23.70 (Est. $22.50) 🟢 $LLY CEO David Ricks: Lilly delivered another strong quarter with XX% revenue growth year-over-year driven by continued demand for our incretin portfolio". " We advanced Orforglipron through four"
X Link @TacticzH 2025-10-30T11:11Z 29.2K followers, 28.3K engagements